Tag Archives: Dementia

A Fresh Look at Solving Brain Diseases: Alzheimer’s and Dementia

Failed strategies for treating Alzheimer’s disease and other types of dementia are prompting a broad rethink on how to tackle the growing prevalence of these costly brain health problems. At the BIO International meeting in San Diego last month there were parallel conversations on these two major brain health challenges – with speakers from the… Read More »

Diet Soda, Your Health, and Your Brain

Diet soda drinkers take note: people who drink one or more diet sodas every day are at greater risk of stroke and dementia. More specifically, habitual diet soda drinkers have almost three times the risk of stroke or dementia compared to their diet soda-abstinent peers, according to a research study published in Stroke. Researchers relied… Read More »

Bilingual Brains Provide More Protection Against Alzheimer’s & Dementia

  If you speak two languages, you’ve given your brain a big boost against Alzheimer’s disease, according to a recent study published in the Proceedings of National Academy of Sciences (PNAS). The PNAS study recruited 85 people from Northern Italy who had all been diagnosed with early stage Alzheimer’s. Forty people in the study spoke… Read More »

High Blood Pressure and Cognitive Decline

More confirmation that high blood pressure (hypertension) directly impacts brain health from this study in the British Medical Journal. The BMJ study followed over 5,000 older adults (average age of 75) for three years, measuring both blood pressure and cognitive health during medical visits performed four times a year. The researchers found a consistent pattern… Read More »

Food Choices Matter for Your Brain Health

“There is no magic pill that fixes a bad diet.” This rather direct advice comes from the lead investigator of a study on the balance of food intake containing Omega 6 & Omega 3 fatty acids, recently published in the PLOS ONE online scientific journal. In general, Omega 3 sources like fish, beans, and green… Read More »

Another Alzheimer’s Drug Candidate Bites the Dust

Add Baxter International’s Gammagard to the ash heap of failed Alzheimer’s drug candidates. Baxter announced today that Gammagard did not provide any cognitive or functional improvement in 390 patients with mild to moderate Alzheimer’s disease. The patients who were enrolled in the Phase III trial received the drug through infusions over an 18 month period.… Read More »